Pfizer Inc.
PFE
$24.86
$0.291.18%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/29/2025 | 03/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.84% | -22.79% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.84% | -22.79% | |||
| Cost of Revenue | 35.11% | -54.86% | |||
| Gross Profit | 0.25% | -7.48% | |||
| SG&A Expenses | 13.20% | -38.57% | |||
| Depreciation & Amortization | 0.00% | -10.89% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 17.52% | -40.48% | |||
| Operating Income | -12.86% | 70.73% | |||
| Income Before Tax | 9.34% | 27,940.00% | |||
| Income Tax Expenses | 174.60% | 55.11% | |||
| Earnings from Continuing Operations | -2.35% | 623.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -200.00% | 25.00% | |||
| Net Income | -1.92% | 623.66% | |||
| EBIT | -12.86% | 70.73% | |||
| EBITDA | -9.51% | 39.54% | |||
| EPS Basic | -2.08% | 623.10% | |||
| Normalized Basic EPS | -14.71% | 89.95% | |||
| EPS Diluted | -1.56% | 628.29% | |||
| Normalized Diluted EPS | -14.51% | 90.04% | |||
| Average Basic Shares Outstanding | 0.18% | 0.14% | |||
| Average Diluted Shares Outstanding | -0.07% | 0.12% | |||
| Dividend Per Share | 0.00% | 2.38% | |||
| Payout Ratio | -- | -0.86% | |||